Search research articles
Contact Us
Filters
Showing results (31-40 of 100) with videos related to
Page
of 10
Sort By:
Therapeutic Drug Monitoring
|
July 3, 2009
A liquid chromatography-tandem mass spectrometry method for the determination of 5-Fluorouracil degradation rate by intact peripheral blood mononuclear cells
Alfonso M Lostia, Luana Lionetto, Cristiano Ialongo, et al.
Cancers
|
October 23, 2021
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
Simona Duranti, Alessandra Fabi, Marco Filetti, et al.
Journal of Clinical Medicine
|
June 26, 2026
Insomnia in Breast Cancer: A Neglected Symptom Cluster
Giuseppe Marano, Ida Paris, Gianandrea Traversi, et al.
American Journal of Clinical Oncology
|
May 19, 2025
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Federica Martorana, Maria V Sanò, Alessandra Fabi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 16, 2022
Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact
Andrea Rosati, Camilla Fedele, Anna Fagotti, et al.
Frontiers in Oncology
|
April 10, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
Roberta Caputo, Giuseppe Buono, Michela Piezzo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2021
Erratum to 'Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis' [Eur J Cancer 149 (2021) 134-152]
Francesco Schettini, Fabiola Giudici, Ottavia Bernocchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2021
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis
Francesco Schettini, Fabiola Giudici, Ottavia Bernocchi, et al.
Frontiers in Oncology
|
November 13, 2023
Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project
Marina Elena Cazzaniga, Antonio Ciaccio, Romano Danesi, et al.
Minerva Surgery
|
August 2, 2021
Techniques for sentinel node biopsy in breast cancer
Sonia Bove, Simona M Fragomeni, Alessia Romito, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 100) with videos related to
Sort By:
Page
of 10
Therapeutic Drug Monitoring
|
July 3, 2009
A liquid chromatography-tandem mass spectrometry method for the determination of 5-Fluorouracil degradation rate by intact peripheral blood mononuclear cells
Alfonso M Lostia, Luana Lionetto, Cristiano Ialongo, et al.
Cancers
|
October 23, 2021
Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
Simona Duranti, Alessandra Fabi, Marco Filetti, et al.
Journal of Clinical Medicine
|
June 26, 2026
Insomnia in Breast Cancer: A Neglected Symptom Cluster
Giuseppe Marano, Ida Paris, Gianandrea Traversi, et al.
American Journal of Clinical Oncology
|
May 19, 2025
A Multicenter Real-Life Evaluation of Safety and Effectiveness of the Antibody-Drug Conjugate Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
Federica Martorana, Maria V Sanò, Alessandra Fabi, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
April 16, 2022
Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impact
Andrea Rosati, Camilla Fedele, Anna Fagotti, et al.
Frontiers in Oncology
|
April 10, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis
Roberta Caputo, Giuseppe Buono, Michela Piezzo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 28, 2021
Erratum to 'Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis' [Eur J Cancer 149 (2021) 134-152]
Francesco Schettini, Fabiola Giudici, Ottavia Bernocchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 16, 2021
Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis
Francesco Schettini, Fabiola Giudici, Ottavia Bernocchi, et al.
Frontiers in Oncology
|
November 13, 2023
Late onset toxicities associated with the use of CDK 4/6 inhibitors in hormone receptor positive (HR+), human epidermal growth factor receptor-2 negative (HER2-) metastatic breast cancer patients: a multidisciplinary, pan-EU position paper regarding their optimal management. The GIOCONDA project
Marina Elena Cazzaniga, Antonio Ciaccio, Romano Danesi, et al.
Minerva Surgery
|
August 2, 2021
Techniques for sentinel node biopsy in breast cancer
Sonia Bove, Simona M Fragomeni, Alessia Romito, et al.
Page
of 10